Clinical evaluation of the effect of siddha classical drug DHASADEEPAKINI CHOORANAM for the treatment of FEVER

Clinical evaluation of the effect of DHASADEEPAKINI CHOORANAM for the treatment of MAANTHASURAM

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029652

Enrollment

Registered

2020-12-08

Start date

Unknown

Completion date

Unknown

Last updated

2022-10-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K30- Functional dyspepsia

Interventions

Intervention1: DHASADEEPAKINI CHOORANAM: Should be administered orally twice a day after food along with hotwater for a period of 5 days dose:1/2-1 gram Control Intervention1: Not applicable: Not appl

Eligibility

Inclusion criteria

Inclusion criteria: subjects with any of the following symptoms will be included in the study 1.Fever 2.Loss of appetite 3.Diarrhoea 4.Stomach bloating 5.Malaise 6.Constipation

Exclusion criteria

Exclusion criteria: 1.Children below 3 years and above 12 years 2.Fever due to systemic illness 3.Pyrexia of unknown origin 4.Fever associated with urinary tract infections 5.Irritable bowel syndrome 6.Severe dehydration

Design outcomes

Primary

Measure	Time frame
Decreases the Body temperature, reducing the symptoms of loss of appetite, diarrhoea, malaise, stomach bloating and constipationTimepoint: 5 days	—

Secondary

Measure	Time frame
Assessment by CBCTimepoint: 5 days	—

Countries

India

Contacts

Public ContactDr D K Soundararajan MDs

Government Siddha Medical College and Hospital, Palayamkottai

dr.dks2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026